Shape Therapeutics Inc., leading in the domain of programmable RNA medicines, offers a stimulating work environment with its forefront use of artificial intelligence and RNA technology. The focus on rare genetic disorders and conditions such as Alzheimer’s and Parkinson’s not only promises high-impact projects but also positions its employees at the cutting edge of medical innovation. ShapeTX's commitment to advancing next-generation AAVs and revolutionizing gene therapy manufacturing ensures continuous learning and growth opportunities for its team.